The disclosure generally relates to medical studies, and more particularly to assessing the complexity of designed medical studies and making subsequent discussions and/or modification to the design of the study based on the complexity assessments.
Clinical trial protocols are designed to produce scientifically sound new knowledge about the safety, efficacy, or specific therapeutic characteristics of a new drug or treatment combination. Clinical trial protocols developed using modern medical study design principles have well-understood statistical hypothesis testing and internal validity characteristics. Thus, modern clinical studies are designed to deliver the most supportable scientific knowledge with the smallest number of study subjects. Despite these more efficient study designs, the complexity and associated costs of executing new protocols continue to increase.
The rising complexity of current protocol designs has resulted in a dramatic increase in the operational management overhead required to initiate, execute, and complete a clinical trial successfully within a budget and a time frame. With the increasing number of patients, investigators, locations and countries involved in a given trial, it is not surprising that many clinical trials have significant operational issues that cause substantial cost/time over-runs or outright trial failures.
A distinction between scientific versus operational issues in clinical trials planning and execution is important. A scientific issue arises due to the limited state of current knowledge about the trial agent(s) pharmacologic and therapeutic properties in the experimental clinical situation. This lack of scientific knowledge is precisely the reason a well-designed clinical trial is required. Scientific issues are ethically justified and do not indicate any problem with the clinical trial protocol. Operational issues arise because of unforeseen difficulties in executing the clinical trial within the strict parameters or assumptions embedded implicitly or explicitly within the protocol design. In this case, the protocol designers may not have been able to predict the difficulties the field organization or clinical investigators have in operationalizing specific study design components. Furthermore, the design protocols vary by therapeutic area, adding to the difficulty in predicting operational issues in clinical trials.
Operational deficiencies can be costly to an organization, especially if they require an amendment to the protocol during execution of the trail. Even simple amendments have substantial costs, including the internal overhead of detecting the need for an amendment, the costs related to creating the amendment, the internal approval costs for releasing the amendment, the costs for disseminating the amendment, and the follow-up effort to ensure that the amendment has been incorporated into the clinical trial process at a potentially large number of trial sites. The cost of an amendment also includes the opportunity costs due to delay in the completion of the medical study or data analysis impact due to inconsistent operational behavior at the trial sites.
One operational element of designing protocols is calculating the protocol complexity. Traditionally, the protocol complexity is determined by multiplying the clinical procedures by the frequency and summing all procedures, which is referred to as a crude estimate of the complexity. For example, if a protocol has ten (10) clinical trial procedures and each procedure must be completed five times during the clinical trial, the complexity value for the protocol would be fifty (50). This methodology has been used to measure complexity. The major drawback of this methodology is that each clinical procedure has the same weight. For example, using the current methodology a blood draw has the same impact on the overall complexity of a clinical trial design as an MRI.
In recent years, there has been a growth in complexity of protocol designs and rising administrative demands to execute more procedures. For example, during the past ten years, drug development programs are targeting chronic illnesses, which are more difficult to treat and require longer and more elaborate methods to measure safety and efficacy. Additionally, regulatory agency requirements may also be attributable to the growing complexity of protocol designs because protocols are being designed to anticipate what regulatory agencies will require. Studies have shown that the more complex a clinical trial protocol is, the less efficient and effective a study may be. Therefore, the studies indicate that improvements to the planning and designing of clinical trial protocols may enhance the efficiency and effectiveness of clinical trails, especially in research-based pharmaceutical and biopharmaceutical industries.
Thus, it would be advantageous to provide a method of improving the planning of a clinical trial by reducing the need for amendments, such as for designs that do not properly estimate the costs and time involved for each procedure, by providing a complexity computation that can be used in the designing and planning process. Additionally, it would be beneficial to design a protocol that allows a physician to assess the complexity of each procedure determined by the cost, time, effort, and expertise required for each procedure.
The present invention includes a system and methods for planning a medical study.
The system for planning a medical study includes a display device and a data store comprising a plurality of medical procedures for at least one of designing and executing a medical study. The system further includes a service delivery device operatively coupled to the display device and the data store. The service delivery device includes a processor and a memory for storing instructions. In response to receiving a request to plan a medical study, the memory causes the processor to (1) select a set of procedures from the plurality of medical procedures; (2) assign a work effort unit for each procedure included in the set of procedures, with the work effort unit based on at least one of procedure type, procedure cost, procedure time, and procedure phase; (3) calculate a complexity level for the set of procedures based on the work effort units; and (4) evaluate whether the complexity level is appropriate for the medical procedure by comparing the calculated complexity level to a threshold level, where the threshold value represents a desirable complexity level for the study.
A first computer-implemented method of planning and executing a medical study includes selecting a set of procedures from a plurality of medical procedures accessible from an electronic data store. Then, a work effort unit is assigned to each procedure included in the set of medical procedures. The work effort unit is based on at least one of procedure type, procedure cost, procedure time, and procedure phase. After that, a complexity level is calculated for the set of procedures based on the work effort units. Finally, the appropriateness of the complexity level is evaluated by comparing the calculated complexity level to a threshold level, where the threshold value represents a desirable complexity level for the study.
A second computer-implemented method of determining a complexity level for a medical study includes determining a work effort unit for each procedure included in a set of medical procedures. The work effort unit is based on at least one of procedure type, procedure cost, procedure time, and procedure phase. Then, all unique procedures included in the set of medical procedures are identified. After that, the work effort unit is multiplied by a number of occurrences of each of the unique procedures in the set of medical procedures. Finally, the multiplied work effort units are summed.
Other objects and features of the present invention will become apparent from the following detailed description considered in conjunction with the accompanying drawings. It is to be understood, however, that the drawings are designed as an illustration only and not as a definition of the limits of the invention.
Like reference symbols in the various drawings indicate like elements.
Medical practices produce a variety of services that can be counted in “relative value units” (RVUs). RVUs are non-monetary, numeric values that Medicare has developed to determine reimbursement rates. RVUs represent the relative amount of physician time, resources, and expertise needed to provide various services to patients. The total RVU reimbursement rates are composed of three component RVU values, which are added together and then multiplied by a conversion factor. The result is a cost Medicare feels is a fair reimbursement for that procedure.
For purposes of planning a clinical trial, the present invention uses the RVU value to calculate the complexity of the procedures. In particular, an RVU value or a RVU-like value will be assigned to every clinical procedure in a clinical trial.
To implement the new value, the present invention will include a table or other data structure capable of listing the unique clinical procedures and other direct costs (ODCs) which have been called for in a clinical trial protocol. Since this invention relates to planning clinical trials for medical studies, clinical procedure values are the most important for the complexity analysis. Most clinical procedures included in the clinical trial have a Current Procedure Terminology (CPT) code and an associated Relative Value Unit (RVU). The procedures without a CPT code are procedures not recognized by the American Medical Association (AMA) and are almost exclusively procedures used in clinical trials, such as questionnaires, scales, and study volunteer assessments. Other clinical procedures which may not have a CPT code are procedures not reimbursed by Medicare, since Medicare deems that the procedures do not include significant work by the physician or the site, such as laboratory procedures.
For clinical procedures without the CPT codes, the unique codes may be assigned according to an internal coding methodology. The internal coding methodology of the present invention is a workload scale based on the estimated costs in administrating the procedure, where the workload factors include the amount of time involved in preparing the clinical procedure, conducting the clinical procedure, and completing the clinical procedure. Examples of clinical trial procedural groupings used for determining the complexity of procedures in a clinical trial may include, but are not limited to the following: (1) lab test, such as laboratory test, panels, and cultures for vitamin levels, infectious and bacterial agents, and toxins; (2) blood work, such as laboratory tests and assays examining hematology and coagulation, such as blood counts, bone marrow compositions, and prothombin/thromboplastin times; (3) questionnaires and subjective assessments, such as self-administered or physician administered questionnaires, rating scales, and assessments for psychological and medical conditions; (4) office consultations and examinations, such as full evaluation and management procedures for both medical and psychological conditions and both new patient and follow-up examination; (5) x-rays and imaging, such as preventative and diagnostic procedures including ultrasounds, cat scans, x-rays, and MRIs; and (6) heart activity assessments, such as ECGs, EKGs, stress tests, and electro-cardiographic monitoring for both diagnostic and preventative purposes.
The service delivery device 16 (or computing device) is operatively connected to the display 12 and the data store 14 and further includes a processor 20 and a memory 22 for storing instructions 24 that, in response to receiving a request to plan a medical study 26, cause the processor 20 to select a set of procedures 28 from the plurality of medical procedures 18 and estimate a cost in administrating at least one procedure included in the set of procedures 28. The instructions stored in the memory 22 may be one or more instructions selected from the list consisting of causing the processor 20 to: (1) identify unique procedures included in the set of procedures; (2) determine a Procedure Work Effort (PWE) by multiplying a work effort unit (WEU) 30 by the number of occurrences of each unique procedure by the WEU and determine a Site Work Effort (SWE) by summing the PWE; (3) estimate a cost in administrating at least one procedure included in the set of procedures; and (4) modify the set of procedures in response to a comparison of the calculated complexity level to a threshold value by adding, removing, or modifying a procedure included in the set of procedures 28. Then, the service delivery device 16 uses the processor to assign the WEU 30 for each procedure 18 included in the set of procedures 28, calculate a complexity level 32 for each set of procedures 28 based on the assigned WEU 30, and evaluate 34 the appropriateness of the complexity level for the set of procedures 28 by comparing the calculated complexity level 32 to a threshold level, where the threshold value represents a desired complexity level for the study.
The WEU 30 is based on at least one of the following: procedure type, procedure cost, procedure time, and procedure phase. The WEU 30 used for the present invention includes RVU values and non-RVU values for each clinical procedure. As shown in
In particular,
Clinical outcomes may also be measured with outcome text 102 and outcome type 104, such as primary efficacy, secondary efficacy, tertiary efficacy, safety, pharmacoeconomic, and/or any other purpose, as shown in
For clinical trial protocols, information of particular importance is the selection of the procedures to be performed, also referred to as tasks. Oftentimes, the complexity of a procedure depends on the type of study (i.e., Phase 1, 2, or 3) and/or the therapeutic area being studied. For example, procedures being performed on a compromised cancer patient in a late stage oncology clinical trial may require more expertise and/or time from the physician than the same procedures performed on a patient enrolled in an allergy trial. Consequently, the invention incorporates a mechanism for selecting a trial phase 112 and trial time 114, as shown in
Once the important design study information has been collected,
The information contained in
Moreover, providing estimates of complexity based on weighted values, such as the cost, the time, the effort, and/or the expertise involved in each procedure, results in improved clinical trials because the valuable assessment tools of the present invention are used in the planning stages of the clinical trial, allowing for multiple assessments and adjustments to procedures based on the evaluation of estimates of the complexity and the objectives of the clinical trial.
It will be appreciated that the present invention has been described herein with reference to certain preferred or exemplary embodiments. The preferred or exemplary embodiments described herein may be modified, changed, added to or deviated from without departing from the intent, spirit and scope of the present invention, and it is intended that all such additions, modifications, amendment and/or deviations be included within the scope of the following claims.
Number | Date | Country | Kind |
---|---|---|---|
61096130 | Sep 2008 | US | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US09/55604 | 9/1/2009 | WO | 00 | 3/4/2011 |